These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10204615)
1. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma. Nagao K; Tomimatsu M; Endo H; Hisatomi H; Hikiji K J Gastroenterol; 1999 Feb; 34(1):83-7. PubMed ID: 10204615 [TBL] [Abstract][Full Text] [Related]
2. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma. El-Mazny A; Sayed M; Sharaf S Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049 [TBL] [Abstract][Full Text] [Related]
4. Genetic diagnostic test of hepatocellular carcinoma by telomerase catalytic subunit mRNA. Wada E; Hisatomi H; Moritoyo T; Kanamaru T; Hikiji K Oncol Rep; 1998; 5(6):1407-12. PubMed ID: 9769378 [TBL] [Abstract][Full Text] [Related]
6. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma. Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181 [TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma. Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104 [TBL] [Abstract][Full Text] [Related]
8. Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy. Hisatomi H; Nagao K; Kanamaru T; Endo H; Tomimatsu M; Hikiji K Int J Oncol; 1999 Apr; 14(4):727-32. PubMed ID: 10087321 [TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954 [TBL] [Abstract][Full Text] [Related]
10. [Expression of telomerase reverse transcriptase and its relationship with tumor suppressor gene p53 in HCC]. Dai D; Zhai W; Zhu T; Zhu H; Ling Y Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():79-81. PubMed ID: 11509149 [TBL] [Abstract][Full Text] [Related]
11. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of human telomerase reverse transcriptase mRNA in the serum of patients with hepatocellular carcinoma. Miura N; Shiota G; Nakagawa T; Maeda Y; Sano A; Marumoto A; Kishimoto Y; Murawaki Y; Hasegawa J Oncology; 2003; 64(4):430-4. PubMed ID: 12759542 [TBL] [Abstract][Full Text] [Related]
13. Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. Onishi T; Nouso K; Higashi T; Toshikuni N; Nakatsukasa H; Kobayashi Y; Uemura M; Yumoto E; Fujiwara K; Sato S; Nakamura S; Yokoyama J; Hanafusa T; Shiratori Y J Gastroenterol Hepatol; 2003 Oct; 18(10):1168-74. PubMed ID: 12974904 [TBL] [Abstract][Full Text] [Related]
14. Dedifferentiation of human hepatocellular carcinoma up-regulates telomerase and Ki-67 expression. Yeh TS; Chen TC; Chen MF Arch Surg; 2000 Nov; 135(11):1334-9. PubMed ID: 11074892 [TBL] [Abstract][Full Text] [Related]
15. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755 [TBL] [Abstract][Full Text] [Related]
16. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214 [TBL] [Abstract][Full Text] [Related]
17. Expression of telomerase component genes in hepatocellular carcinomas. Takahashi S; Kitamoto M; Takaishi H; Aikata H; Kawakami Y; Nakanishi T; Shimamoto F; Tahara E; Tahara H; Ide T; Kajiyama G Eur J Cancer; 2000 Mar; 36(4):496-502. PubMed ID: 10717526 [TBL] [Abstract][Full Text] [Related]
18. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213 [TBL] [Abstract][Full Text] [Related]
19. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194 [TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase. Zhang R; Wang X; Guo L; Xie H Int J Cancer; 2002 Jan; 97(2):173-9. PubMed ID: 11774261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]